Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A new preprint study found that six days of statin exposure reduced coenzyme Q levels in rat astrocytes by 30–40%, impairing mitochondrial energy production and increasing harmful hydrogen peroxide output. Statins work by blocking the mevalonate pathway, which also governs CoQ biosynthesis, raising questions about unintended effects on brain cell function. The findings suggest CoQ10 supplementation could potentially protect astrocyte mitochondria from statin-induced dysfunction, though the research is at an early, pre-peer-review stage.
Researchers publishing on bioRxiv report that atorvastatin and simvastatin — two widely prescribed cholesterol-lowering drugs — reduced the total mitochondrial coenzyme Q (mtCoQ) pool in rat astrocytes by 30–35% and the antioxidant form (mtCoQH2) by approximately 40% after six days of treatment at 200 nM concentrations. These reductions were accompanied by decreased respiratory activity, lower mitochondrial membrane potential, reduced ATP synthesis, and elevated hydrogen peroxide production during oxidation of complex I and complex II substrates. The organization of the mitochondrial respiratory chain was also disrupted, with downregulation of key supercomplexes and decreased protein levels and activity across all respiratory chain complexes. Notably, levels of mitochondrial antioxidant proteins such as superoxide dismutase 2 and uncoupling proteins were unchanged, suggesting the oxidative stress arose specifically from CoQ depletion rather than a broader antioxidant collapse. CoQ10 supplementation restored mtCoQ levels, recovered respiratory function, and reduced hydrogen peroxide production in statin-treated cells, pointing to a potential protective intervention. Because astrocytes play a central role in maintaining brain redox homeostasis, the authors argue that statin-induced mitochondrial dysfunction in these cells could contribute to central nervous system pathology. The study is a preprint and has not yet undergone formal peer review.
What's missing
The study was conducted exclusively in rat astrocyte cell cultures, and it is unclear whether these findings translate to human astrocytes or to clinically relevant statin doses and durations. The research does not address whether the observed mitochondrial changes produce measurable neurological effects in vivo, nor does it examine whether patients on statins show corresponding CoQ deficits in brain tissue.
What different sources said
- bioRxivCenter
Statin-Induced Mitochondrial Coenzyme Q Deficiency Alters Mitochondrial Redox Homeostasis and Bioenergetic Function in Astrocytes
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.